Curriculum - General Description
All four tracks are research-oriented and will combine rigorous coursework with sufficient
time for intensive research activity. Previous students on average have completed
the Ph.D. in approximately five years, and the M.S. program in about 3 years or less.
Graduates progress to post-doctoral training (Ph.D. degree graduates) or to research,
teaching, and other scientific positions in academia, industry, and the government
(Ph.D. and M.S. degree graduates).
All incoming Ph.D. and M.S. students enter the program after choosing a specific track, although not a specific advisor. All students take a common core of coursework and rotate though faculty laboratories during the first year. The common core of coursework all students take in the first year is rigorous, integrated, and helps to promote fruitful cross-fertilization between disciplines. Students then align with a faculty major advisor and begin the Ph.D. dissertation or M.S. thesis research project. Students complete any additional track-specific coursework and their research project during ensuing years. Students who maintain a 3.0 or higher GPA are eligible to take the Qualifying Exam no later than the end of their first year (M.S. students), or second year (Ph.D. students). Students who pass both the written and oral QE then become official candidates for their graduate degree and will subsequently spend the majority of their remaining training time performing thesis (M.S.) or dissertation (Ph.D.) research under the guidance of their major advisor and faculty committee members.
Our recent graduates from the Ph.D./M.S. in Biomedical Science program have received research positions at leading academic institutions, government, and industry. Institutions include Centers for Disease Control, Cold Spring Harbor Laboratories, Columbia University, Cornell University, Fox Chase Cancer Center, Gliatech, Immusol, Johns Hopkins University, Harvard University, Merck, National Institutes of Health, National Institute of Environmental Health Sciences, Pfizer, Salk Research Institute, Stanford University, University of Pennsylvania, Vanderbilt University, University of Michigan, and Yale University.